Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

2 results loaded, newest first. End of these results.

News 2026-10-23 19:40 UTC

FDA Approves Subcutaneous Induction Regimen For Abbvie's Skyrizi For Adults With Moderately To Severely Active Crohn's Disease

News 2026-10-23 19:34 UTC

The FDA approved a subcutaneous induction regimen of AbbVie’s SKYRIZI for adults with moderately to severely active Crohn’s disease.